BioCentury
ARTICLE | Company News

Abilita deal

February 3, 2017 9:20 PM UTC

Abilita partnered with an undisclosed pharmaceutical company to use its EMP membrane protein evolution platform to discover and develop proteins that target GPCRs. Abilita will receive an upfront paym...

BCIQ Company Profiles

Abilita Therapeutics Inc.